兰德-A-Review-of-the-Dementia-Research-Landscape-and-Workforce-Capacity-in-the-United-Kingdom_116页_1mb

Summary of the Dementia Research Landscape and Workforce Capacity in the United Kingdom

Core Content

This report provides an independent review of the UK's dementia research landscape and workforce capacity, commissioned by the Alzheimer's Society. It aims to inform a blueprint for research capacity-building in dementia by examining both the strengths and limitations of the current research environment and identifying key challenges and opportunities for researchers.

The review was conducted using three main methods:

1. Bibliometric analysis: Using publication data to assess the UK's research performance globally, based on citation impact.
2. PhD tracing: Investigating the retention of UK dementia research graduates and their career progression.
3. Qualitative interviews: Engaging with stakeholders from various sectors to explore the strengths, gaps, and opportunities in the UK dementia research system and workforce.

Key Findings

Dementia Research Landscape

• The UK is the second-largest producer of dementia-related research globally (1980–2013), with a high citation impact.
• Alzheimer's disease accounts for 60.5% of all UK dementia publications, while other types of dementia (e.g., Lewy body dementia, frontotemporal dementia) account for 0.1% to 6.1%.
• Clinical medicine is the most prolific field, followed by neurology and neurosurgery, and geriatrics.
• The UK has pockets of excellence in various subfields, such as medicinal and biomolecular chemistry, pharmacology, general and internal medicine, nuclear medicine, and pathology.
• However, some subfields, like epidemiology, speech-language pathology, virology, and biophysics, have lower citation impact.

PhD Graduates in Dementia Research

• 21% of dementia PhD graduates remain in dementia research, with a higher-end estimate of 38%.
• 43% of graduates remain in research careers (in dementia or other areas), and 48% of these continue to focus on dementia-related topics.
• 25% of active UK dementia researchers obtained their PhDs in the UK but are now based in other countries (e.g., USA, Canada, Germany, Australia).
• The UK dementia research workforce has a 2.3:1 ratio of junior/mid-level to senior researchers, similar to other biological and medical fields but higher than in medicine and dentistry.

Stakeholder Insights

• The UK dementia research landscape is diverse, with strengths in:
  • Genetics research (e.g., Alzheimer's and Parkinson's disease).
  • Brain imaging for disease progression.
  • Lewy body dementia and person-centred care.
  • Epidemiological work with cohort studies.
  • Amyloid hypothesis and related research.
• Identified gaps and limitations include:
  • Limited understanding of cellular mechanisms in dementia.
  • Insufficient clinician involvement in research.
  • Underinvestment in care-related research (e.g., nursing, social care).
  • Challenges in clinical trial conduct, including recruitment, incentives, and diagnosis accuracy.
  • Limited industry engagement and translational research focus.
  • Short-term funding and lack of permanent academic positions.
  • Transition bottlenecks from postdoctoral to lecturer roles, and from PhD to first postdoc positions.

Opportunities and Challenges

• The lack of a secure career path is a major challenge for researchers, particularly in the transition from postdoctoral roles to independent positions.
• There is a need for increased awareness of dementia research opportunities and a shift in attitude towards the field.
• Career bottlenecks are particularly pronounced in clinical and allied health professions, due to time constraints, undervaluation, and limited funding.
• Support mechanisms include:
  • Junior and mid-career fellowships.
  • Flexible employment arrangements for healthcare professionals.
  • Leadership and skill development training.
  • Long-term funding and sustainability planning for research centres and networks.
  • Collaboration across disciplines and sectors.

Policy Recommendations

The report proposes ten key areas for policy action to support dementia research and workforce development:

Actions to Support Individuals

1. Scale up existing schemes and introduce mechanisms to address bottlenecks in the transition from postdoctoral to independent investigator and lecturer roles.
2. Increase the flow of future talent and address transition bottlenecks from PhD to postdoc.
3. Reflect on the specific research career needs of different stakeholder groups.
4. Support professional skill development, including leadership, communication, and grant writing.

Actions to Support Institutions and Networks

5. Ensure the long-term sustainability of dementia research centres and networks.
6. Establish mechanisms to attract researchers from diverse fields to collaborate.
7. Strengthen interdisciplinary collaboration and networking.
8. Promote translational research and industry engagement.
9. Enhance funding diversity and long-term investment.
10. Develop career development pathways and succession planning for key researchers.

Conclusion

The UK has demonstrated global leadership in dementia research, but significant challenges remain in terms of workforce capacity and research sustainability. Addressing these challenges through evidence-based strategies will be crucial for nurturing a vibrant and sustainable dementia research workforce and maintaining international excellence in the field. The proposed policy actions aim to foster constructive dialogue and innovation in the UK dementia research landscape.